November 9, 2023 | Advisors, DSL advisor, DSL advisory, Digital advisory boards, HCP advisor, HCP advisory, KOL advisor, MSL advisor, MSL advisory, Online advisory board, Virtual advisory boards, WHy are virtual advisory boards, online ad board, virtual ad board
We’re breaking down the benefits of virtual advisory boards, and how they are superior when compared to in-person and hybrid advisory boards.
#6. Far Superior Convenience
Most KOLs have extremely busy work and personal schedules. Even finding a time for a one- or two-hour webinar that works with all advisors’ schedules can be challenging. Accordingly, having the ability to log in and interact with other advisors from anywhere at any time on any device is one of the most important advantages of online advisory boards.
The asynchronous nature of the online touchpoints allows Pharma teams to engage with KOLs in larger geographical areas. There is no longer a need to worry about time zones or language barriers. Non-native English speakers are able to take their time when formulating their responses. They can also leverage automatic language translation features to write and read others’ comments in their preferred language.
To learn more about this and other great benefits of virtual advisory boards, check out our blog https://www.impetusdigital.com/2021/09/17/top-10-benefits-of-virtual-advisory-boards/
Interested in learning how we can help you engage your advisors, HCPs, patients, and stakeholders with expertly executed virtual meetings and programs? Visit us at www.impetusdigital.com or talk to one of our amazing team members via https://meetwithimpetus.com/
Follow us on social media
https://linkedin.com/company/impetus-digital
https://twitter.com/impetus_digital
https://facebook.com/ImpetusDigital.fb
https://impetusdigital.com/podcast/
#AdvisoryBoard #HCP #DOL #KOL #advisors #OnlineAdvisoryBoard #VirtualAdvisoryBoard
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health...
Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...
Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...
Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.
Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma...
Curtis Khan, CEO and Founder of BookJane, discusses the ongoing caregiver crisis and how BookJane’s solutions and other digital technologies can help to close this gap. We also delve into how...
Ramsay Brown, CEO and Founder of Quol, delves into several different HealthTech topics, including the concept of VR therapeutics and the importance of incorporating behavioral science and neuroscience into VR solutions, as...
Rodney Hu, founder of 209|Digital and a popular podcast host. We explore Rodney’s work within the HealthTech space and what he believes has to happen for the healthcare industry to more...
Sandra Graham-Mason, Director of Marketing at Regeneron Pharmaceuticals discusses a variety of topics, from the impact of COVID-19 on the way that Pharma teams interact with internal stakeholders and KOLs to...
Dr. Phillip Alvelda, CEO and Co-Founder of Brainworks, discusses all things artificial intelligence and machine learning. We also explore the concepts of whole-brain AI systems and ambient biometrics, and how AI-enhanced vital...